Intervention

Nevirapine

ClinicalTrials.gov intervention label

Clinical trials96

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

60 shown

Neuropsychiatric Side Effects of Efavirenz in Children Living With HIVNCT03227653 · 2017-06-19

Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected PatientsNCT03664440 · 2016-12-01

Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, BotswanaNCT03088410 · 2016-08-22

Antiretroviral Regime for Viral Eradication in NewbornsNCT02712801 · 2016-04-01

Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialNCT02431975 · 2015-08-01

Early Infant HIV Treatment in BotswanaNCT02369406 · 2015-05-04

ACTIVE_NOT_RECRUITING

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)NCT02116660 · 2014-09-03

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral TherapyNCT01789879 · 2014-03-04

Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedNCT01632891 · 2014-01-10

A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and LactationNCT02269462 · 2012-12-01

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)NCT01637558 · 2012-11-01

Influence of Nevirapine on HCV Viral LoadNCT01277627 · 2011-01-01

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTNCT00719602 · 2009-08-01

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandNCT00672412 · 2008-10-01

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV PatientsNCT00661349 · 2008-02-01

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TBNCT01805258 · 2007-06-01

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During BreastfeedingNCT00074412 · 2007-01-01

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenNCT00312091 · 2006-12-01

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV TransmissionNCT00089505 · 2006-11-01

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African CommunitiesNCT00255840 · 2006-07-01

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving BirthNCT00109590 · 2006-06-01

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVNCT00270296 · 2006-06-01

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)NCT00234091 · 2006-04-01

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenNCT00260078 · 2006-02-01

Pharmacokinetics Study on Nevirapine Resistance in TanzaniaNCT00294892 · 2006-02-01

Case-Control Viramune (Nevirapine) Toxicogenomics StudyNCT00310843 · 2006-02-01

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIVNCT00307151 · 2005-12-01

ATV/Ritonavir Nevirapine Interaction (USPAC)NCT00162149 · 2005-10-01

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthNCT00102960 · 2005-07-01

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive PatientsNCT00199979 · 2005-04-01

Preventing Sexual Transmission of HIV With Anti-HIV DrugsNCT00074581 · 2005-02-01

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVNCT00307502 · 2005-01-01

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues OnlyNCT00415090 · 2004-08-01

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in UgandaNCT00639938 · 2004-07-01

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV TransmissionNCT00115648 · 2004-04-01

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVNCT00144157 · 2003-06-01

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-DyslipidemiaNCT00405171 · 2003-06-01

Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in WeightNCT01335360 · 2003-05-01

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)NCT00192660 · 2003-02-01

Prevention of Milk-Borne Transmission of HIV-1C in BotswanaNCT00197587 · 2002-08-01

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyNCT00017719 · 2002-05-01

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsNCT00028314 · 2002-03-01

Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric PatientsNCT00273975 · 2002-01-01

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ PatientsNCT00274001 · 2001-09-01

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenNCT00016601 · 2001-06-01

Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive PatientsNCT02181946 · 2001-05-01

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVNCT00074399 · 2001-02-01

Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected PatientsNCT02184286 · 1999-05-01

Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected PatientsNCT02184299 · 1999-04-01

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive AdultsNCT02182765 · 1999-04-01

Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive WomenNCT02181933 · 1999-04-01

Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ PatientsNCT02184078 · 1998-10-01

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected WomenNCT02182791 · 1998-04-01

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and StavudineNCT00001688 · 1998-01-01

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV InfectionNCT00001644 · 1997-03-03

A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected ChildrenNCT00000634

Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsNCT00021463

A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected ChildrenNCT00001111

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV DiseaseNCT00002166

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentNCT00004581

Common conditions

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)44 Boehringer Ingelheim18 Abbott2 Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2 Bristol-Myers Squibb2 Germans Trias i Pujol Hospital2 Harvard School of Public Health (HSPH)2 International Maternal Pediatric Adolescent AIDS Clinical Trials Group2 Radboud University Medical Center2 Adeniyi Olagunju1 All India Institute of Medical Sciences1 Ann & Robert H Lurie Children's Hospital of Chicago1 CIPRA SA1 Columbia University1 Hospital de Calella1

Trial status mix

COMPLETED87

TERMINATED5

UNKNOWN2

ACTIVE_NOT_RECRUITING1

WITHDRAWN1

Phase mix

PHASE225

PHASE322

PHASE121

NA15

PHASE413

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.